Zhenlong K. Yu
Lvshun South Road
Dalian, 116044, China
Dalian, 116044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Unveiling C1QBP: A New Guardian of Dopaminergic Neuron in Parkinson's disease by targeting ULK1 to promote mitophagy and maintain mitochondrial function.
Journal: Free radical biology & medicine
Published: January 19, 2026
RBM14 enhances transcriptional activity of p23 regulating CXCL1 expression to induce lung cancer metastasis.
Journal: Acta pharmaceutica Sinica. B
Published: October 25, 2024
CLIP170 enhancing FOSL1 expression via attenuating ubiquitin-mediated degradation of β-catenin drives renal cell carcinoma progression.
Journal: Cellular and molecular life sciences : CMLS
Published: July 11, 2024
Elemene as a binding stabilizer of microRNA-145-5p suppresses the growth of non-small cell lung cancer.
Journal: Journal of pharmaceutical analysis
Published: April 23, 2024
Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer.
Journal: iScience
Published: April 10, 2024
Hepatocyte aquaporin 8-mediated water transport facilitates bile dilution and prevents gallstone formation in mice.
Journal: Journal of hepatology
Published: February 01, 2024
Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death.
Journal: Biomaterials
Published: January 24, 2024
Correction: Characterization of a small-molecule inhibitor targeting NEMO/IKKβ to suppress colorectal cancer growth.
Journal: Signal transduction and targeted therapy
Published: September 04, 2023
Correction: Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells.
Journal: Molecular cancer
Published: September 02, 2023
Last Updated: 09/26/2026